Radicle Recharge: A Study of Health and Wellness Products on Energy Levels and Other Health Outcomes

Sponsor
Radicle Science (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT06104891
Collaborator
(none)
2,000
1
4
6.2
323.8

Study Details

Study Description

Brief Summary

A randomized, double blind, placebo-controlled trial assessing the immediate impact of non-caffeinated supplements on energy levels and associated health outcomes

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Recharge Placebo Control 1
  • Dietary Supplement: Recharge Active Study Product 1
  • Dietary Supplement: Recharge Active Study Product 2
  • Dietary Supplement: Recharge Active Study Product 3
N/A

Detailed Description

This is a randomized, double blind. placebo-controlled study conducted with adult participants (study volunteers, citizen scientists), at least 21 years of age at the time of consent and attending the Supply Side West Meeting (SSW) this year.

Eligible participants will (1) endorse a desire for more energy and (2) express acceptance in taking a product and not knowing its formulation until the end of the study.

Participants that report a known contraindication or with well-established, significant safety concerns due to illness and/or medication(s) will be excluded. Participants that report a known allergy to any possible ingredient they may be exposed to in one of the study arms will be excluded.

Participants will take their assigned study product at a Radicle booth, after enrolling.

Participant reported outcomes (PROs) are collected electronically from eligible participants at baseline (before study product consumption, and for a period of 5 hours after consuming their study product.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be stratified based on gender at birth, then randomized to one of the study armsParticipants will be stratified based on gender at birth, then randomized to one of the study arms
Masking:
Double (Participant, Investigator)
Masking Description:
Participants will be blinded to the product they receive.
Primary Purpose:
Other
Official Title:
Radicle Rechargeā„¢: A Randomized, Double-blind, Placebo-controlled Trial Assessing the Immediate Effects of Non-caffeinated Supplements on Energy Levels and Associated Health Outcomes
Anticipated Study Start Date :
Oct 25, 2023
Anticipated Primary Completion Date :
Oct 26, 2023
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo Control 1

Recharge Product Form 1 - control

Dietary Supplement: Recharge Placebo Control 1
Participants will use their Radicle Recharge Placebo Control 1 as directed for a period of 5 hours.

Experimental: Active Product 1

Recharge Product Form 2 - active product 1

Dietary Supplement: Recharge Active Study Product 1
Participants will use their Radicle Recharge Active Study Product 1 as directed for a period of 5 hours.

Experimental: Active Product 2

Recharge Product Form 3 - active product 1

Dietary Supplement: Recharge Active Study Product 2
Participants will use their Radicle Recharge Active Study Product 2 as directed for a period of 5 hours.

Experimental: Active Product 3

Recharge Product Form 4 - active product 1

Dietary Supplement: Recharge Active Study Product 3
Participants will use their Radicle Recharge Active Study Product 3 as directed for a period of 5 hours.

Outcome Measures

Primary Outcome Measures

  1. Change in energy [5 hours]

    Mean difference in energy score as assessed by Energy Visual Analog Scale (VAS) (scale 0 - 10; where 0 is no energy and 10 is more than enough energy)

Secondary Outcome Measures

  1. Change in cognitive function [5 hours]

    Mean difference in cognitive function score as assessed by Patient Reported Outcome Measurement System (PROMIS) Cognitive Function - Abilities 4A (scale 4-20; where lower scores correspond to worse cognitive function). Modified timing to, "since walking this morning"

  2. Change in fatigue [5 hours]

    Mean difference in fatigue score as assessed by Fatigue VAS (scale 0 - 10; where 0 is no fatigue and 10 is completely exhausted)

  3. Minimal clinically important difference (MCID) in energy [5 hours]

    Likelihood of experiencing MCID in energy score as assessed by Energy VAS

  4. Minimal clinically important difference (MCID) in cognitive function [5 hours]

    Likelihood of experiencing MCID in cognitive function score as assessed by PROMIS Cognitive Function - Abilities 4A

  5. Minimal clinically important difference (MCID) in fatigue [5 hours]

    Likelihood of experiencing MCID in fatigue score as assessed by Fatigue VAS

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 105 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults at least 21 years of age at the time of electronic consent, inclusive of all ethnicities, races, sexes, and gender identities

  • Attending the Supply Side West meeting in person

  • Able to read and understand English

  • Endorses more energy as a primary desire

  • Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study

Exclusion Criteria:
  • Reports being pregnant, trying to become pregnant, or breastfeeding

  • Reports current enrollment in another clinical trial

  • Reports a cardiac disease that presents an absolute contraindication and/or a significant safety concern with any of the study product ingredients.

  • Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study products ingredients: Anticoagulants, chemotherapy, immunotherapy, medications that warn against grapefruit consumption, oral diabetic medications, or oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection

  • Reports an allergy to any of the study products ingredients

Contacts and Locations

Locations

Site City State Country Postal Code
1 Radicle Science, Inc Del Mar California United States 92014

Sponsors and Collaborators

  • Radicle Science

Investigators

  • Principal Investigator: Emily K. Pauli, PharmD, Radicle Science

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Radicle Science
ClinicalTrials.gov Identifier:
NCT06104891
Other Study ID Numbers:
  • RADX-2317
First Posted:
Oct 27, 2023
Last Update Posted:
Oct 27, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2023